British journal of haematology · 2001
Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
van der Straaten H M, Fijnheer R, Dekker A W, Nieuwenhuis H K, Verdonck L F
Аннотация
The success of allogeneic bone marrow transplantation (BMT) is limited by the major complications, graft-versus-host disease (GVHD) and relapse. The very beneficial effect of maximal T-cell depletion of the graft for prevention of GVHD has been counterbalanced by an increase in graft failure and relapse of disease. Therefore, we started an approach of partial T-cell depletion of the graft. GVHD and graft-versus-leukaemia (GVL) are strongly correlated after non-T cell-depleted BMT. Here, we report whether the correlation between GVHD and GVL also exists in partial T cell-depleted BMT from sibling donors. We retrospectively studied 117 adult patients with early haematological malignancies. Our method of partial T-cell depletion gave a relapse rate in patients with acute leukaemias similar to that observed in non-T cell-depleted BMT. However, patients with chronic myeloid leukaemia had a relapse rate that was similar to that observed in maximal T cell-depleted BMT. We found a significant correlation between the presence of chronic GVHD and an improved disease-free survival. Nevertheless, overall survival was lower in patients with chronic GVHD. There was no correlation between the occurrence of acute GVHD and disease-free or overall survival.
Предметные рубрики MeSH
Acute DiseaseAdultBone Marrow TransplantationChronic DiseaseDisease-Free SurvivalFemaleGraft vs Host DiseaseGraft vs Leukemia EffectHumansLeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, MyeloidLymphocyte DepletionMaleMiddle AgedPrecursor Cell Lymphoblastic Leukemia-LymphomaRecurrenceRetrospective StudiesSurvival RateT-LymphocytesTransplantation, Homologous